NCT04159454View on ClinicalTrials.gov

PITA-HF: Feasibility, Safety, and Tolerability

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

November 20, 2020

Primary Completion Date

February 1, 2023

Study Completion Date

February 1, 2023

Conditions
Heart FailureDilated Cardiomyopathy
Interventions
DEVICE

PITA

Patients will have PITA turned on to patients' existing Medtronic devices, such that patients will be RV-paced from midnight to 6 AM each night at a rate \~10 beats per minute (BPM) above patients' baseline heart rates during this time period as determined by Holter monitors.

Trial Locations (1)

21287

Johns Hopkins Hospital, Baltimore

Sponsors

Collaborators (1)

Medtronic
All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

Johns Hopkins University

OTHER

NCT04159454 - PITA-HF: Feasibility, Safety, and Tolerability | Biotech Hunter | Biotech Hunter